2022 Build to Scale Program
B. Ellerman
B. Ellerman
UArizona may submit a maximum of two proposals (e.g. 2 RED Innovation Track or 1 RED A&I Track and 1 RED Two-year Track).
For all tracks, the Principal Investigator must be a department chair/head (or equivalent) to provide leadership for the change process. Due to this requirement, this opportunity is Institutionally Coordinated.
Ticket #1: R. van der Pijl
Ticket #2: Available
UArizona may submit two applications.
No applicants // Limit: 2 // Tickets Available: 2
No applicants // Limit: 2 // Tickets Available: 2
The Sexual Violence Research Initiative (SVRI) is inviting applications for innovative research that will contribute to the prevention and response of violence against women (VAW), violence against children (VAC) and other forms of violence driven by gender inequality in low and middle income countries.
No applicants // Limit: 1 // Tickets Available: 1
While HRSA-22-124 is a stand-alone limited submission, UArizona may only submit one application to HRSA-22-122, HRSA-22-124, or HRSA-22-122. Therefore, submissions to these funding opportunities are Institutionally Coordinated and only the selected PI is eligible to submit. Please Contact Bekah Coskun, Associate, Biomedical, Clinical & Health Sciences, RDS, with any questions.
No applicants // Limit: 1 // Tickets Available: 1
While HRSA-22-117 is not a limited submission, UArizona may only submit one application to HRSA-22-122, HRSA-22-124, or HRSA-22-122. Therefore, submissions to these funding opportunities are Institutionally Coordinated and only the selected PI is eligible to submit. Please Contact Bekah Coskun, Associate, Biomedical, Clinical & Health Sciences, RDS, with any questions.
K. Ernst
While HRSA-22-122 is not a limited submission, UArizona may only submit one application to HRSA-22-122, HRSA-22-124, or HRSA-22-122. Therefore, submissions to these funding opportunities are Institutionally Coordinated and only the selected PI is eligible to submit. Please Contact Bekah Coşkun, Associate, Biomedical, Clinical & Health Sciences, RDS, with any questions.
J. Armin
S. Fleming
W. Burleson
J. Roveda
H. Hua
M. Barton
M. Van Dyke
June 2022 update: RII/RDS has identified proposal teams who are working on concept outlines. PIs interested in collaborating on a concept outline should please email RDS with questions.